.Nature Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint requires introduction of individuals along with MASLD and dimension of liver results in cardio-- kidney-- metabolic tests, when information suggest mechanistically possible perks and professional security-- and describes considerations for trial design and also governing commendation.